Published on
Last updated on
Vaccine Administration Law
On 29.06.2019, NMPA minister Jiao Hong attended a press briefing - held by the general office of the NPCSC (The Standing Committee of the National People's Congress) - regarding the vaccine administration law. Jiao Hong stated to implement a very strict administration over vaccines. The Law clearly defines a stringent management system, vaccine development, production, and circulation of vaccines. Penalties related to counterfeit or substandard vaccines are far heavier than those for general drugs.
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.